Durability of Antibody Removal Following Proteasome Inhibitor-Based Therapy
. .
Experience with proteasome inhibitors (PI) for treating antibody-mediated rejection (ABMR) and HLA antibody removal is increasing. However, the durability of the effects PI on HLA antibody removal is unknown. This study examines this question from a unique point of view due to the use of the PI bortezomib as either a combination therapy or a […]
Comments Off on Durability of Antibody Removal Following Proteasome Inhibitor-Based Therapy
Posted in Renal Transplantation
Recent Comments